Lilly All Set To Conduct another Successful Trial of Alzheimer's Drug

Lilly All Set To Conduct another Successful Trial of Alzheimer's Drug

A recent research has shed light on an experimental Alzheimer's drug, by Eli Lilly & Company, which might be able to deal with the mild cases. However, they would have to go for another trial in order to confirm that the drug, solanezumab, is effective enough.

The makers have apparently observed that the drug is capable enough to slow memory decline, while they conducted the research on over 1000 patients earlier. After the research, they found that some 34% mild Alzheimer's patients faced reduced mental decline for a period of 18 months.

Thus before approaching U. S. regulatory approval, the makers are going for another trial to confirm their results. There are fair chances of the research to be over by the second half of 2015, and hopefully, the drug would be able to make its way in the market in 2017.

"We are committed to working with the F. D. A. and other regulatory authorities to bring solanezumab to the millions of patients and caregivers suffering from this devastating disease who urgently need this potential treatment", said David Ricks, a senior vice president at Lilly and president of Lilly Bio-Medicines.

Though the shares of the company saw a rise of 16% after the initial results in August, they faced a drop of $1.60, or 3.2%, to $49, after the announcement of the second trial.


FrenchTribune Specials

Increasing Acidic Level in Oceans Makes Fish Lose their Survival Instinct

Yet another consequence of climate change has been revealed. Novel research has found fish lose their survival instinct when affected by acid and they look for their predators.

Researchers from James Cook University have found that as the world's oceans are becoming more acidic in nature due to climate change, fish are getting attracted...

Most Popular

Numerous Options to View Rare Blood Moon

The first total lunar eclipse of 2014 will take place on...

Jenny McCarthy clears her stand and says she is pro-vaccine

Jenny MsCarthy is now trying hard to undo the ill-...

Along with new mothers, new fathers too have risk of depression

A recent study has shown that young fathers too have an...

South Korea’s state health insurer sues Philip Morris for smoking damages

The National Health Insurance Service (NHIS) has said in...

Poll

Can Greece Come out of Economic Problems: